Johannes A Bogaards Selected Research

Neoplasms (Cancer)

11/2023	Health and economic effects of introducing single-dose or two-dose human papillomavirus vaccination in India.
11/2022	Evidence-based impact projections of single-dose human papillomavirus vaccination in India: a modelling study.
11/2020	The cost-effectiveness profile of sex-neutral HPV immunisation in European tender-based settings: a model-based assessment.
1/2019	Capturing multiple-type interactions into practical predictors of type replacement following human papillomavirus vaccination.
10/2018	Who Will Benefit From Expanding HPV Vaccination Programs to Boys?
1/2017	Health and Economic Impact of a Tender-Based, Sex-Neutral Human Papillomavirus 16/18 Vaccination Program in the Netherlands.
5/2015	Direct benefit of vaccinating boys along with girls against oncogenic human papillomavirus: bayesian evidence synthesis.
7/2011	Long-term impact of human papillomavirus vaccination on infection rates, cervical abnormalities, and cancer incidence.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Johannes A Bogaards Research Topics

Disease

15	Infections 01/2022 - 02/2003
8	Neoplasms (Cancer) 11/2023 - 07/2011
7	Papillomavirus Infections 01/2022 - 12/2011
6	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2023 - 01/2013
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/2015 - 07/2011
3	Acquired Immunodeficiency Syndrome (AIDS) 02/2006 - 02/2003
2	Warts (Wart) 01/2021 - 01/2017
2	HIV Infections (HIV Infection) 02/2006 - 02/2003
1	Fatigue 10/2023
1	Myositis (Idiopathic Inflammatory Myopathies) 10/2023
1	Anus Neoplasms (Anal Cancer) 01/2020
1	Hepatitis B 01/2019
1	Coinfection 01/2019
1	Carcinoma (Carcinomatosis) 05/2015
1	Carcinogenesis 07/2011
1	Disease Progression 10/2003
1	Viremia 10/2003

Drug/Important Bio-Agent (IBA)

21	VaccinesIBA 11/2023 - 10/2003
4	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 04/2010
3	Papillomavirus Vaccines (HPV Vaccines)IBA 01/2022 - 02/2013
2	Combined VaccinesIBA 01/2020 - 01/2018
2	AntibodiesIBA 01/2015 - 07/2006
1	Prednisone (Sone)FDA LinkGeneric 10/2023
1	GlucocorticoidsIBA 10/2023
1	SteroidsIBA 10/2023
1	Intravenous Immunoglobulins (IVIG)FDA Link 10/2023
1	insulin receptor-related receptor (IRR)IBA 01/2023
1	Doxycycline (Periostat)FDA LinkGeneric 01/2017
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2017
1	Viral AntigensIBA 01/2015
1	CR3022IBA 07/2006
1	Monoclonal AntibodiesIBA 07/2006
1	RNA (Ribonucleic Acid)IBA 02/2006
1	AIDS VaccinesIBA 10/2003

Therapy/Procedure

2	Highly Active Antiretroviral Therapy (HAART) 02/2006 - 02/2003
1	Therapeutics 02/2003